Senior Security Engineer, Application Security
Trail of Bits- Full Time
- Senior (5 to 8 years)
The Senior Security Engineer should possess a strong understanding of security principles, network architecture, and operating systems, with experience in vulnerability scanning, penetration testing, and bug bounties. They must be able to analyze the potential impact of vulnerabilities, assess the likelihood of exploitation, and prioritize vulnerabilities for remediation. Additionally, the candidate should have experience managing the vulnerability lifecycle, driving automation initiatives, and ensuring alignment with industry standards.
This role involves proactively identifying, assessing, and mitigating security risks within the organization’s systems and networks through techniques such as vulnerability scanning, penetration testing, and bug bounties. The Security Engineer will work with engineering, IT, and other teams to implement patches and mitigation strategies, validate remediation efforts, and continuously monitor systems for new vulnerabilities. Furthermore, they will drive automation of vulnerability scanning and assessment processes, integrate security into the software development lifecycle, and collaborate with other teams to enhance the organization’s overall security posture while maintaining security controls and compliance requirements for handling sensitive data.
Designs precision biologics using in vivo methods
Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.